SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001477932-17-004399
Filing Date
2017-09-11
Accepted
2017-09-08 20:15:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B5 ipix_424b5.htm 424B5 257044
  Complete submission text file 0001477932-17-004399.txt   258224
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-199725 | Film No.: 171077692
SIC: 2834 Pharmaceutical Preparations